PRESS RELEASE published on 02/23/2023 at 20:00, 2 years 3 months ago Abivax publishes a prospectus in the context of its capital increase
PRESS RELEASE published on 02/23/2023 at 20:00, 2 years 3 months ago Abivax annonce la mise à disposition d’un prospectus dans le cadre de son augmentation de capital
PRESS RELEASE published on 02/22/2023 at 18:05, 2 years 3 months ago Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
PRESS RELEASE published on 02/22/2023 at 18:05, 2 years 3 months ago Abivax annonce le succès d’un financement cross-over sursouscrit de 130 millions d’euros au prix du marché, par des investisseurs américains et européens de premier plan
PRESS RELEASE published on 02/17/2023 at 08:00, 2 years 3 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/17/2023 at 08:00, 2 years 3 months ago Abivax: Le Dr. Sheldon Sloan, M.D., est nommé Directeur Médical d’Abivax
PRESS RELEASE published on 02/14/2023 at 18:00, 2 years 3 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 02/14/2023 at 18:00, 2 years 3 months ago Abivax présentera lors du 18ème Congrès de l’ECCO des données issues d’échantillons sanguins et de biopsies rectales de patients atteints de RCH et traités avec obefazimod
PRESS RELEASE published on 01/31/2023 at 18:00, 2 years 4 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/31/2023 at 18:00, 2 years 4 months ago ABIVAX: AVIS AUX PORTEURS D’OBLIGATIONS CONVERTIBLES/ECHANGEABLES EN ACTIONS NOUVELLES ET/OU EXISTANTES (OCEANES) D’UN MONTANT NOMINAL DE 24 999 975,99 EUROS
Published on 06/04/2025 at 22:30, 12 hours 50 minutes ago Revolve to Present at 2025 Canadian Climate Investor Conference
Published on 06/04/2025 at 21:30, 13 hours 50 minutes ago Nepra Foods Inc. Issues Clarification on Revenue Disclosure
Published on 06/04/2025 at 20:30, 14 hours 50 minutes ago Crisis Hits U.S. Automotive Manufacturing Because of Chinese Restrictions on Heavy Rare Earth Exports
Published on 06/04/2025 at 19:00, 16 hours 20 minutes ago Shareholders Approved June 4, 2025 Resolutions - Notice of Court Application June 6, 2025
Published on 06/05/2025 at 11:00, 20 minutes ago ABB Ltd: ABB share buybacks - May 29, 2025 - June 4, 2025
Published on 06/05/2025 at 11:00, 20 minutes ago Avemio Group bildet strategische Allianz mit Host Broadcast Services (HBS)
Published on 06/05/2025 at 11:00, 20 minutes ago GBC AG initiates coverage on Somec S.p.A. – Leading niche player entering phase of margin expansion
Published on 06/05/2025 at 10:45, 35 minutes ago Wolftank Group awarded environmental contracts in Italy worth EUR 51.5m
Published on 06/05/2025 at 10:15, 1 hour 5 minutes ago OPPO Licenses Cellular Standard-Essential Patents to Volkswagen Group for Connected Vehicles
Published on 06/05/2025 at 10:04, 1 hour 16 minutes ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/05/2025
Published on 06/05/2025 at 09:58, 1 hour 22 minutes ago Déclaration du nombre d’actions et droits de vote au 31 mai 2025
Published on 06/05/2025 at 09:58, 1 hour 22 minutes ago Disclosure of Share Capital and Voting Rights as of May 31, 2025
Published on 06/04/2025 at 18:05, 17 hours 15 minutes ago Déclaration nombre d'actions et droits de vote - 04.06.2025
Published on 06/04/2025 at 18:05, 17 hours 15 minutes ago Disclosure of shares outstanding and voting rights - 04.06.2025
